LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Neratinib | 0.00043333 | 12.88 | 84.90 | 1125 | 531 | 2.1186 | 1.6565 | MN20160318_Q02 | G05 |
| MCF 10A-H2B-mCherry | Neratinib | 0.00043333 | 12.88 | 84.90 | 1 | 531 | 0.0019 | -0.8135 | MN20160318_Q02 | H08 |
| MCF 10A-H2B-mCherry | Neratinib | 0.00043333 | 12.88 | 84.90 | 1003 | 531 | 1.8889 | 1.5437 | MN20160318_Q02 | H08 |
| MCF 10A-H2B-mCherry | Neratinib | 0.00043333 | 14.58 | 84.90 | 121 | 663 | 0.1824 | 0.1269 | MN20160318_Q02 | G05 |
| MCF 10A-H2B-mCherry | Neratinib | 0.00043333 | 14.58 | 84.90 | 1177 | 663 | 1.7742 | 1.4265 | MN20160318_Q02 | G05 |
| MCF 10A-H2B-mCherry | Neratinib | 0.00043333 | 14.58 | 84.90 | 72 | 663 | 0.1085 | -0.0540 | MN20160318_Q02 | H08 |
| MCF 10A-H2B-mCherry | Neratinib | 0.00043333 | 14.58 | 84.90 | 1099 | 663 | 1.6566 | 1.3710 | MN20160318_Q02 | H08 |
| MCF 10A-H2B-mCherry | Neratinib | 0.00043333 | 16.29 | 84.90 | 331 | 766 | 0.4316 | 0.5350 | MN20160318_Q02 | G05 |
| MCF 10A-H2B-mCherry | Neratinib | 0.00043333 | 16.29 | 84.90 | 1300 | 766 | 1.6952 | 1.3617 | MN20160318_Q02 | G05 |
| MCF 10A-H2B-mCherry | Neratinib | 0.00043333 | 16.29 | 84.90 | 128 | 766 | 0.1669 | 0.1381 | MN20160318_Q02 | H08 |
| MCF 10A-H2B-mCherry | Neratinib | 0.00043333 | 16.29 | 84.90 | 1192 | 766 | 1.5544 | 1.2981 | MN20160318_Q02 | H08 |
| MCF 10A-H2B-mCherry | Neratinib | 0.00043333 | 17.99 | 84.90 | 364 | 898 | 0.4049 | 0.5336 | MN20160318_Q02 | G05 |
| MCF 10A-H2B-mCherry | Neratinib | 0.00043333 | 17.99 | 84.90 | 1398 | 898 | 1.5551 | 1.2770 | MN20160318_Q02 | G05 |
| MCF 10A-H2B-mCherry | Neratinib | 0.00043333 | 17.99 | 84.90 | 240 | 898 | 0.2670 | 0.3570 | MN20160318_Q02 | H08 |
| MCF 10A-H2B-mCherry | Neratinib | 0.00043333 | 17.99 | 84.90 | 1264 | 898 | 1.4060 | 1.2106 | MN20160318_Q02 | H08 |
| MCF 10A-H2B-mCherry | Neratinib | 0.00043333 | 19.69 | 84.90 | 995 | 1239 | 0.8028 | 0.8896 | MN20160318_Q02 | G05 |
| MCF 10A-H2B-mCherry | Neratinib | 0.00043333 | 19.69 | 84.90 | 1557 | 1239 | 1.2562 | 1.1215 | MN20160318_Q02 | G05 |
| MCF 10A-H2B-mCherry | Neratinib | 0.00043333 | 19.69 | 84.90 | 733 | 1239 | 0.5914 | 0.7460 | MN20160318_Q02 | H08 |
| MCF 10A-H2B-mCherry | Neratinib | 0.00043333 | 19.69 | 84.90 | 1362 | 1239 | 1.0989 | 1.0494 | MN20160318_Q02 | H08 |
| MCF 10A-H2B-mCherry | Neratinib | 0.00043333 | 21.40 | 84.90 | 1438 | 1454 | 0.9885 | 0.9944 | MN20160318_Q02 | G05 |
| MCF 10A-H2B-mCherry | Neratinib | 0.00043333 | 21.40 | 84.90 | 1680 | 1454 | 1.1549 | 1.0715 | MN20160318_Q02 | G05 |
| MCF 10A-H2B-mCherry | Neratinib | 0.00043333 | 21.40 | 84.90 | 1155 | 1454 | 0.7940 | 0.8906 | MN20160318_Q02 | H08 |
| MCF 10A-H2B-mCherry | Neratinib | 0.00043333 | 21.40 | 84.90 | 1503 | 1454 | 1.0332 | 1.0160 | MN20160318_Q02 | H08 |
| MCF 10A-H2B-mCherry | Neratinib | 0.00043333 | 23.10 | 84.90 | 1549 | 1616 | 0.9584 | 0.9801 | MN20160318_Q02 | G05 |
| MCF 10A-H2B-mCherry | Neratinib | 0.00043333 | 23.10 | 84.90 | 1789 | 1616 | 1.1069 | 1.0484 | MN20160318_Q02 | G05 |